Here's your Forbes Daily Briefing for Friday, May 9th.

Today on Forbes, We Govy Deal makes co-founder of hair loss pill seller Hymns a billionaire.

Andrew Dudum, co-founder of San Francisco-based online pharmacy Hymns and Hers,

a seller of wellness products for men and women, including hair loss

and erectile dysfunction pills, is now a billionaire. This comes after strong quarterly earnings

and a recent deal to sell a popular weight loss drug, sent the company's stock soaring.

Hems and hers stock continued its upward climb on Wednesday, with the company's market cap close to $12 billion at market close.

Two days earlier, the company reported a 111% jump in revenue for the first quarter to $586 million, up from $278 million for the same quarter last year. Net income also shot up to $49.5 million

from $11.1 million a year ago. Also driving up the stock? In April 29th announcement that Hymns and

hers struck a partnership with the Danish pharmaceutical company, Novo Nordisk,

to sell its popular weight loss drug, Wegovi, through Hymns and Hers online pharmacy.

That makes it one of just three telehealth providers now able to sell the popular drug.

Novo Nordisk makes both Wegovi and OZempic.

OZempic was developed for patients with type 2 diabetes.

The company's stock has rocketed up 73% since the announcement,

reversing a dramatic tumble that followed a February decision by the Food and Drug Administration

to stop telehealth companies like Hymns and HERS for making compound versions of Novo Nordisk's

weight loss drug.

Companies, including Hems and hers hers were allowed to manufacture and sell the drugs

after a sudden boom in their popularity led to shortages of the key ingredient,

semaglutide.

The recent rally has boosted the net worth of the 36-year-old Dudum, a serial entrepreneur who helped launch the

...